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A 79-year-old woman was admitted with a giant chestwall mass (Figures 1 and 2) and symptoms of dyspnoea
that were progressively aggravated during the last 3
months. The mass was initially detected by the patient 1
year earlier, but she did not ask for medical consultation
because of its initial small dimensions and the lack of
symptoms. The patient underwent uncomplicated re-
section of the giant mass (measuring 34 cm in its ma-
ximal dimension and weighting 6.9 kg) en bloc with the
muscles in contact. The tumor destroyed the third through
seventh ribs, and these were also resected; the chest wall
defect was reconstructed with a 2-mm e-polytetrafluoro-
ethylene mesh. Re-establishment of the chest wall shape
and re-expansion of the left lung had as result relief of
dyspnoea symptoms and improvement of the quality of
life. Histologic and immunohistochemical examination
of the tumor established the diagnosis of high-grade myx-
oid malignant fibrous histiocytoma (MFH)/myxofibro-
sarcoma. The tumor was predominantly composed of
myxoid areas (50%) with spindle cells and intermediate
atypia and nonmyxoid areas with high cellularity and
atypia. The immunohistochemical stainings for vim-
entin, myoglobulin, CD68, and CD34 (focally) were pos-
itive, whereas the stainings for smooth muscle actin and
desmin were negative.
Despite MFHs are the most common soft tissue
sarcomas in adults, primary MFHs of the chest wall are
relatively rare tumors.1,2 MFHs tend to reach large dimen-
sions if left untreated within short periods of time. Radical
surgery is the optimal treatment for MFHs of the chest wall
including all the surrounding structures in contact with the
tumor, even if the tumor has large dimensions. Local
recurrence is observed in 30% of cases, probably as the
result of nonradical surgery or spread of tumor cells within
the operative field during resection or extirpation of large
tumors.2
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FIGURE 1. Computed tomography scan of the chest: huge
inhomogeneous chest wall mass compressing the left chest
wall and inverting the concave of the ribs. The left lung is al-
most entirely collapsed because of external compression. The
compressed left lateral chest wall tends to reach the pericardium.
FIGURE 2. Huge chest wall mass occupying the whole pos-
terolateral left chest wall.
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